Skip to main content
Premium Trial:

Request an Annual Quote

Asuragen Licenses MicroRNA IP From Rockefeller University

NEW YORK (GenomeWeb News) – Asuragen licensed microRNA sequences from Rockefeller University to develop early cancer detection tools, the company said today.
 
Under the semi-exclusive agreement, Asuragen will have access to microRNAs identified by a group led by Thomas Tuschl. These microRNAs are involved with human diseases like diabetes and cancer.
 
Financial details were not disclosed.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.